Terms: = Gastric cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
8 results:
1. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic values of stromal tumor-infiltrating lymphocytes and lymphocyte-activation gene-3 in advanced gastric adenocarcinoma].
Wu ZD; Wang JC; Zhang HJ; Lin JQ; Wu ZZ; Zheng XW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1007-1012. PubMed ID: 36207914
[No Abstract] [Full Text] [Related]
3. Relationship between levels of serum gastric inhibitory polypeptide (GIP), soluble interleukin-2 receptor (sil-2R), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and disease condition and prognosis of patients with severe acute pancreatitis.
Zeng L; Xi F; Yang Y; Guo L; Hu H; Yang Q; Ma Q
Ann Palliat Med; 2021 Jun; 10(6):6786-6792. PubMed ID: 34154356
[TBL] [Abstract] [Full Text] [Related]
4. Soluble interleukin‑2 receptor as a factor associated with angiogenesis in gastric cancer.
Yan WF; Nie CF; Wu G; Zhang JC; Zhu YZ; Zhang W; Sun PC
Mol Med Rep; 2017 Nov; 16(5):6916-6919. PubMed ID: 28901504
[TBL] [Abstract] [Full Text] [Related]
5. [Effect of early intestinal dripping of jianpi tongli Chinese herbs on serum level IL-2, sil-2R and IL-12 in patients with gastric cancer after operation].
Yu QS; Liu Y; Hou Y; Zhang F; Yi W; Wang X; Shuai J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug; 25(8):710-3. PubMed ID: 16152828
[TBL] [Abstract] [Full Text] [Related]
6. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
[TBL] [Abstract] [Full Text] [Related]
7. Increased serum concentration of circulating soluble receptor for interleukin-2 and its effect as a prognostic indicator in cachectic patients with gastric and colorectal cancer.
Shibata M; Takekawa M
Oncology; 1999; 56(1):54-8. PubMed ID: 9885378
[TBL] [Abstract] [Full Text] [Related]
8. Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.
Nakata B; Chung KH; Kato Y; Yamashita Y; Inui A; Arimoto Y; Maeda K; Onoda N; Sawada T; Sowa M
Br J Cancer; 1998 Jun; 77(11):1820-4. PubMed ID: 9667652
[TBL] [Abstract] [Full Text] [Related]
